GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » Cyclically Adjusted Price-to-FCF

Meta Biomed Co (XKRX:059210) Cyclically Adjusted Price-to-FCF : (As of Jun. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Meta Biomed Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Meta Biomed Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Biomed Co Cyclically Adjusted Price-to-FCF Chart

Meta Biomed Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Meta Biomed Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Meta Biomed Co's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Meta Biomed Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meta Biomed Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Meta Biomed Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Meta Biomed Co's Cyclically Adjusted Price-to-FCF falls into.



Meta Biomed Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Meta Biomed Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Meta Biomed Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-120.559/118.8477*118.8477
=-120.559

Current CPI (Mar. 2024) = 118.8477.

Meta Biomed Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -18.051 99.353 -21.593
201409 -142.883 99.608 -170.481
201412 -144.780 99.098 -173.634
201503 12.153 99.720 14.484
201506 -1.461 100.050 -1.735
201509 -82.653 100.110 -98.123
201512 -24.755 100.220 -29.356
201603 -112.993 100.560 -133.542
201606 14.880 100.790 17.546
201609 90.782 101.460 106.340
201612 -39.141 101.560 -45.804
201703 -51.052 102.850 -58.993
201706 60.374 102.610 69.928
201709 -127.527 103.490 -146.452
201712 -356.675 102.990 -411.593
201803 -446.681 104.100 -509.962
201806 869.849 104.130 992.793
201809 -1,121.497 105.650 -1,261.593
201812 -5.123 104.350 -5.835
201903 -40.153 104.490 -45.670
201906 -72.972 104.880 -82.690
201909 -102.681 105.200 -116.002
201912 -8.806 105.120 -9.956
202003 -44.792 105.540 -50.440
202006 -26.117 104.870 -29.598
202009 88.830 106.200 99.409
202012 48.403 105.765 54.390
202103 -51.694 107.357 -57.227
202106 149.945 107.579 165.652
202109 166.243 108.759 181.664
202112 140.741 109.676 152.510
202203 77.587 111.806 82.474
202206 -122.360 114.083 -127.471
202209 -42.284 114.831 -43.763
202212 -186.531 115.200 -192.437
202303 -179.945 116.550 -183.493
202306 -35.774 117.140 -36.296
202309 124.764 119.111 124.488
202312 31.302 118.848 31.302
202403 -120.559 118.848 -120.559

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Meta Biomed Co  (XKRX:059210) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Meta Biomed Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Biomed Co (XKRX:059210) Business Description

Traded in Other Exchanges
N/A
Address
634 Yeonje-ri, Gangoe-myeon, Cheongwon-gun, Chungbuk, KOR, 363-951
Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co (XKRX:059210) Headlines

No Headlines